Literature DB >> 6420025

Effect of cimetidine premedication on morphine-induced ventilatory depression.

A M Lam, J L Clement.   

Abstract

The potential respiratory interaction between morphine and cimetidine was studied by determining resting ventilation, PETCO2 and ventilatory response to added carbon dioxide in eight healthy volunteers on three separate occasions following administration of : (1) cimetidine 600 mg p.o., (2) morphine 10 mg IM, (3) morphine 10 mg IM preceded by cimetidine 600 mg p.o. Individual entry into the study was randomized and separated by at least one week. All measurements were determined at time 0, 30, 60, 120, 180, 240, 360, 480, 600, 720 minutes and at the end of 24 hours. In addition, serum morphine levels were measured in six subjects during the first six hours following morphine administration. Cimetidine alone had negligible respiratory effects. Morphine alone reduced resting ventilation, elevated PETCO2 and reduced the ventilatory response to added CO2, while the morphine-cimetidine combination caused a more profound depression of the CO2 response and delay in its recovery. No significant difference between resting ventilation and PETCO2 was observed. We conclude that cimetidine premedication interacts with morphine to prolong the respiratory depression but the magnitude of this interaction is small and clinically insignificant in healthy subjects. Caution, however, should be exercised in susceptible patients.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6420025     DOI: 10.1007/BF03011481

Source DB:  PubMed          Journal:  Can Anaesth Soc J        ISSN: 0008-2856


  18 in total

1.  Acid-aspiration prophylaxis by use of preoperative oral administration of cimetidine.

Authors:  D W Coombs; D Hooper; T Colton
Journal:  Anesthesiology       Date:  1979-10       Impact factor: 7.892

Review 2.  Drug therapy: Cimetidine.

Authors:  W Finkelstein; K J Isselbacher
Journal:  N Engl J Med       Date:  1978-11-02       Impact factor: 91.245

3.  How physicians use cimetidine: a survey of hospitalized patients and published cases.

Authors:  R R Schade; R M Donaldson
Journal:  N Engl J Med       Date:  1981-05-21       Impact factor: 91.245

4.  Delayed clearance of diazepam due to cimetidine.

Authors:  U Klotz; I Reimann
Journal:  N Engl J Med       Date:  1980-05-01       Impact factor: 91.245

5.  Cimetidine premedication in elective caesarean section.

Authors:  B G Pickering; R J Palahniuk; M Cumming
Journal:  Can Anaesth Soc J       Date:  1980-01

6.  A survey of cimetidine prescribing.

Authors:  A E Cocco; D V Cocco
Journal:  N Engl J Med       Date:  1981-05-21       Impact factor: 91.245

7.  Variability of ventilatory responses to hypoxia and hypercapnia.

Authors:  S A Sahn; C W Zwillich; N Dick; R E McCullough; S Lakshminarayan; J V Weil
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1977-12

8.  Cimetidine does not alter morphine disposition in man.

Authors:  P Mojaverian; I L Fedder; P H Vlasses; H H Rotmensch; M L Rocci; B N Swanson; R K Ferguson
Journal:  Br J Clin Pharmacol       Date:  1982-12       Impact factor: 4.335

9.  Cimetidine: interaction with oral anticoagulants in man.

Authors:  M J Serlin; R G Sibeon; S Mossman; A M Breckenridge; J R Williams; J L Atwood; J M Willoughby
Journal:  Lancet       Date:  1979-08-18       Impact factor: 79.321

10.  Cimetidine in the prevention of acid aspiration during anesthesia.

Authors:  P Kirkegaard; O Sørensen; P Kirkegaard
Journal:  Acta Anaesthesiol Scand       Date:  1980       Impact factor: 2.105

View more
  3 in total

1.  The role of H2 receptor antagonist premedication in pregnant day care patients.

Authors:  J G Stock; A D Sutherland
Journal:  Can Anaesth Soc J       Date:  1985-09

Review 2.  Pharmacokinetic drug interactions in anaesthetic practice.

Authors:  M Wood
Journal:  Clin Pharmacokinet       Date:  1991-10       Impact factor: 6.447

Review 3.  Drug interactions of clinical significance with opioid analgesics.

Authors:  P M Maurer; R R Bartkowski
Journal:  Drug Saf       Date:  1993-01       Impact factor: 5.606

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.